| scholarly article | Q13442814 |
| P2093 | author name string | V. J. Bubb | |
| R. Schlegel | |||
| M. Conrad | |||
| P2860 | cites work | The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions | Q24337640 |
| A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer | Q24555647 | ||
| A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions | Q24599668 | ||
| At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells | Q29618360 | ||
| Disruption of genes encoding subunits of yeast vacuolar H(+)-ATPase causes conditional lethality | Q33568063 | ||
| Efficient transactivation and morphologic transformation by bovine papillomavirus genes expressed from a bovine papillomavirus/simian virus 40 recombinant virus | Q33678641 | ||
| The E5 oncoprotein of bovine papillomavirus binds to a 16 kd cellular protein | Q33916978 | ||
| Genetic and biochemical definition of the bovine papillomavirus E5 transforming protein | Q33929466 | ||
| Translation of open reading frame E5 of bovine papillomavirus is required for its transforming activity | Q35595257 | ||
| Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma | Q35989372 | ||
| Bovine papillomavirus contains multiple transforming genes | Q36422987 | ||
| The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes | Q36650838 | ||
| A glutamine residue in the membrane-associating domain of the bovine papillomavirus type 1 E5 oncoprotein mediates its binding to a transmembrane component of the vacuolar H(+)-ATPase | Q36656196 | ||
| The E5 oncoprotein target: A 16-kDa channel-forming protein with diverse functions | Q36715662 | ||
| The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture | Q36797743 | ||
| Transforming activity of E5a protein of human papillomavirus type 6 in NIH 3T3 and C127 cells | Q36809556 | ||
| Transforming activity of a 16-amino-acid segment of the bovine papillomavirus E5 protein linked to random sequences of hydrophobic amino acids. | Q36831412 | ||
| 44-amino-acid E5 transforming protein of bovine papillomavirus requires a hydrophobic core and specific carboxyl-terminal amino acids | Q36846314 | ||
| Human papillomavirus type 16 DNA-induced malignant transformation of NIH 3T3 cells | Q36857744 | ||
| Characterization of primary human keratinocytes transformed by human papillomavirus type 18. | Q36868528 | ||
| Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. | Q36886337 | ||
| Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells | Q37119249 | ||
| Identification of a second transforming region in bovine papillomavirus DNA | Q37580560 | ||
| The evolution of H+-ATPases | Q38253585 | ||
| The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3T3 and rat-1 cells | Q40141212 | ||
| Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein | Q41080345 | ||
| Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. | Q42817558 | ||
| Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor | Q42824847 | ||
| The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus | Q42824855 | ||
| The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors | Q42835148 | ||
| Bovine papillomavirus E5 oncoprotein binds to the 16K component of vacuolar H(+)-ATPases | Q44490670 | ||
| Cellular Transformation by Human Papillomavirus DNA in Vitro | Q44575660 | ||
| Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization | Q45383630 | ||
| Use of anticontamination primers in the polymerase chain reaction for the detection of human papilloma virus genotypes in cervical scrapes and biopsies | Q45845012 | ||
| Membrane protein association by potential intrarnembrane charge pairs | Q59054338 | ||
| Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides | Q67674743 | ||
| Papillomaviruses in human cancers | Q69853193 | ||
| Purification and properties of aminoendopeptidase from rat epidermis | Q70382675 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6170-6178 | |
| P577 | publication date | 1993-10-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein | |
| P478 | volume | 67 |
| Q33766992 | A role for HPV16 E5 in cervical carcinogenesis |
| Q58420668 | Alkyl-imino sugars inhibit the pro-oncogenic ion channel function of human papillomavirus (HPV) E5 |
| Q41997624 | Analyses of variant human papillomavirus type-16 E5 proteins for their ability to induce mitogenesis of murine fibroblasts |
| Q81298973 | Are transforming properties of the bovine papillomavirus E5 protein shared by E5 from high-risk human papillomavirus type 16? |
| Q36933987 | Bap31 is a novel target of the human papillomavirus E5 protein |
| Q59358796 | Beyond Channel Activity: Protein-Protein Interactions Involving Viroporins |
| Q40860423 | Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation |
| Q34291548 | Biology of human papillomaviruses |
| Q81311229 | Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor beta receptor in naturally occurring bovine urinary bladder tumours |
| Q35106361 | Bovine papillomavirus type 2 (BPV-2) E5 oncoprotein binds to the subunit D of the V₁-ATPase proton pump in naturally occurring urothelial tumors of the urinary bladder of cattle |
| Q34296041 | CD1d, a Sentinel Molecule Bridging Innate and Adaptive Immunity, Is Downregulated by the Human Papillomavirus (HPV) E5 Protein: a Possible Mechanism for Immune Evasion by HPV |
| Q37350422 | Cellular and molecular biological aspects of cervical intraepithelial neoplasia |
| Q47553261 | Cellular redox, cancer and human papillomavirus |
| Q36989890 | Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses |
| Q42800144 | Codon optimization of the HPV-16 E5 gene enhances protein expression |
| Q40287199 | Cottontail rabbit papillomavirus E8 protein is essential for wart formation and provides new insights into viral pathogenesis |
| Q35543857 | Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice |
| Q89601840 | De novo emergence of adaptive membrane proteins from thymine-rich genomic sequences |
| Q33788778 | Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses |
| Q40755894 | Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins |
| Q39681753 | E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis |
| Q35873508 | E5 proteins of human papillomavirus types 11 and 16 transactivate the c-fos promoter through the NF1 binding element |
| Q35852665 | Effect of human papillomavirus type 16 oncogenes on MAP kinase activity. |
| Q33755082 | Endoplasmic reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH. |
| Q37125290 | Expression of human papilloma virus type 16 E5 protein in amelanotic melanoma cells regulates endo-cellular pH and restores tyrosinase activity |
| Q42803602 | Expression of the bovine papillomavirus type 1 E5B gene reveals a protein-protein interaction of the E5A and E5B gene products |
| Q40056596 | Genes involved in cell adhesion, cell motility and mitogenic signaling are altered due to HPV 16 E5 protein expression |
| Q91932316 | Genome Plasticity in Papillomaviruses and De Novo Emergence of E5 Oncogenes |
| Q41820272 | Golgi alkalinization by the papillomavirus E5 oncoprotein |
| Q37066141 | Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention |
| Q40092543 | HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells |
| Q39533661 | HPV16 E5 affects the KGFR/FGFR2b-mediated epithelial growth through alteration of the receptor expression, signaling and endocytic traffic. |
| Q37016544 | HPV16 E5 and KGFR/FGFR2b interplay in differentiating epithelial cells |
| Q43065744 | HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes |
| Q33958050 | Human papillomavirus 16 E5 modulates the expression of host microRNAs |
| Q33805191 | Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis |
| Q38311763 | Human papillomavirus E5 oncoproteins bind the A4 endoplasmic reticulum protein to regulate proliferative ability upon differentiation |
| Q33962694 | Human papillomavirus immortalization and transformation functions |
| Q38172151 | Human papillomavirus oncoproteins and apoptosis (Review). |
| Q37769103 | Human papillomavirus oncoproteins: pathways to transformation |
| Q35871748 | Human papillomavirus type 11 and 16 E5 represses p21(WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes |
| Q39870770 | Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line |
| Q34757163 | Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation |
| Q53275556 | Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value. |
| Q36550902 | Human papillomaviruses and cervical cancer |
| Q34208269 | Human papillomaviruses and the interferon response |
| Q35196630 | Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation |
| Q33604559 | Induction of CD8 T cells by vaccination with recombinant adenovirus expressing human papillomavirus type 16 E5 gene reduces tumor growth |
| Q37411628 | Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein |
| Q24656125 | Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoproteins |
| Q33183198 | Mechanisms of cell transformation by papillomavirus E5 proteins |
| Q33614547 | Membrane orientation of the human papillomavirus type 16 E5 oncoprotein |
| Q53385379 | Modelling of the human papillomavirus type 16 E5 protein. |
| Q34314053 | Modification of membrane permeability by animal viruses. |
| Q35545566 | Modulation of apoptosis by human papillomavirus (HPV) oncoproteins. |
| Q24559793 | Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth |
| Q59352781 | Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus-Host Protein Network |
| Q35861099 | Mutational analysis of human papillomavirus type 11 E5a oncoprotein |
| Q40638007 | Oligomerization of the E5 protein of human papillomavirus type 16 occurs through multiple hydrophobic regions. |
| Q73562231 | Overexpression, purification, and structural analysis of the hydrophobic E5 protein from human papillomavirus type 16 |
| Q35642759 | Papillomavirus E5: the smallest oncoprotein with many functions |
| Q41159507 | Papillomavirus infections--a major cause of human cancers |
| Q58764248 | Papillomaviruses and Endocytic Trafficking |
| Q34349416 | Pathogenesis of human papillomaviruses in differentiating epithelia |
| Q37145237 | Phosphorylation of the human papillomavirus type 16 E1--E4 protein at T57 by ERK triggers a structural change that enhances keratin binding and protein stability |
| Q33902897 | Prevention of cervix cancer. |
| Q42825151 | Protein kinase C- and ras-dependent activation of c-jun gene by human papillomavirus type 11 E5a oncoprotein |
| Q34757262 | Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle |
| Q44559513 | Quercetin elevates p27(Kip1) and arrests both primary and HPV16 E6/E7 transformed human keratinocytes in G1. |
| Q39036718 | Recent advances in preclinical model systems for papillomaviruses |
| Q37254288 | Recombination-dependent oligomerization of human papillomavirus genomes upon transient DNA replication |
| Q38149888 | Roles of regulated intramembrane proteolysis in virus infection and antiviral immunity |
| Q35860678 | Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16. |
| Q41647867 | Signalling by Src family kinases: lessons learnt from DNA tumour viruses |
| Q98881813 | Structural and functional impacts of E5 genetic variants of human papillomavirus type 31 |
| Q54217605 | Targeting Head and Neck Cancer by Vaccination. |
| Q27490470 | The Canine Papillomavirus E5 Protein Signals from the Endoplasmic Reticulum |
| Q57218500 | The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma |
| Q34754347 | The E5 proteins |
| Q39806231 | The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation. |
| Q37232535 | The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections |
| Q42807820 | The HPV-16 E5 oncogene and bafilomycin A(1) influence cell motility |
| Q34108143 | The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes |
| Q40833610 | The HPV16 E5 oncogene inhibits endocytic trafficking |
| Q93048605 | The Known and Potential Intersections of Rab-GTPases in Human Papillomavirus Infections |
| Q37319770 | The bovine papillomavirus E5 protein and the PDGF beta receptor: it takes two to tango |
| Q44208144 | The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface |
| Q39877479 | The bovine papillomavirus type 4 E8 protein binds to ductin and causes loss of gap junctional intercellular communication in primary fibroblasts |
| Q40008672 | The first hydrophobic region of the HPV16 E5 protein determines protein cellular location and facilitates anchorage-independent growth |
| Q41301893 | The genetic program of genital human papillomaviruses in infection and cancer |
| Q91887783 | The human papillomavirus 16 E5 gene potentiates MmuPV1-Dependent pathogenesis |
| Q40627005 | The human papillomavirus HPV2a E5 protein localizes to the Golgi apparatus and modulates signal transduction |
| Q40751517 | The human papillomavirus type 16 (HPV-16) E5 protein sensitizes human keratinocytes to apoptosis induced by osmotic stress |
| Q34178284 | The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification |
| Q42829683 | The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27(Kip1). |
| Q35362775 | The human papillomavirus type 16 E5 oncoprotein translocates calpactin I to the perinuclear region |
| Q39686155 | The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms |
| Q40912192 | The human papillomavirus type 16 E5 protein modulates phospholipase C-gamma-1 activity and phosphatidyl inositol turnover in mouse fibroblasts |
| Q33180948 | The platelet-derived growth factor beta receptor as a target of the bovine papillomavirus E5 protein |
| Q52193731 | Viral proteins of bovine papillomavirus type 4 during the development of alimentary canal tumours. |
| Q41374895 | Virocrine transformation |
| Q35909826 | YIP1 family member 4 (YIPF4) is a novel cellular binding partner of the papillomavirus E5 proteins |
Search more.